Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

Details for Australian Patent Application No. 2005267603 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Donello, John E.

Agent Davies Collison Cave

Pub. Number AU-A-2005267603

PCT Pub. Number WO2006/011915

Priority 10/881,901 30.06.04 US

Filing date 4 March 2005

Wipo publication date 2 February 2006

International Classifications

A61K 31/4168 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/011915 Priority application(s): WO2006/011915

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267605-Method and device for detecting feline immunodeficiency virus

2005267599-Wheat protein isolates and their modified forms and methods of making